Literature DB >> 24691743

Naturally occurring aristolochic acid analogues and their toxicities.

Johanna Michl1, Martin J Ingrouille, Monique S J Simmonds, Michael Heinrich.   

Abstract

Covering: 1960 to 2013. Aristolochic acids are known for causing aristolochic acid nephropathy, a renal fibrosis often associated with urothelial carcinoma. Aristolochic acid I and II are considered to be the cause of these nephrotoxic and carcinogenic effects. However a variety of aristolochic acid analogues, including aristolactams and 4,5-dioxoaporphines have been reported. Their implications in aristolochic acid nephropathy have possibly been overlooked. In this report, in vivo and in vitro toxicity and mutagenicity of these three classes of compounds are discussed. Furthermore, the review gives an update of aristolochic acids, aristolactams and 4,5-dioxoaporphines reported between 2003 and 2013 and their biological activities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24691743     DOI: 10.1039/c3np70114j

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  31 in total

Review 1.  Quality and safety of herbal medical products: regulation and the need for quality assurance along the value chains.

Authors:  Michael Heinrich
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

2.  The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy.

Authors:  Jiafa Ren; Nathan P Rudemiller; Yi Wen; Xiaohan Lu; Jamie R Privratsky; Steven D Crowley
Journal:  Kidney Int       Date:  2019-08-13       Impact factor: 10.612

3.  Exposure to aristolochic acid I is associated with poor prognosis of liver cancer patients.

Authors:  Lan Wang; Shi-Hao Bai; Shu-Jin Song; Zhao-Ning Lu; Jian Huang; Ze-Guang Han
Journal:  Toxicol Res (Camb)       Date:  2022-01-29       Impact factor: 3.524

4.  3,4- and 3,5-Disubstituted 2-Pyridones Using an Intermolecular Cycloaddition / Cycloreversion Strategy: Toward the Synthesis of Aristopyridinone A.

Authors:  Maren K Leibowitz; Ethan S Winter; Jonathan R Scheerer
Journal:  Tetrahedron Lett       Date:  2015-10-28       Impact factor: 2.415

5.  Revisiting traditional Chinese materia medica from European historical collections and perspective for current use.

Authors:  Yusheng Jia; Mei Wang; Tinde van Andel
Journal:  J Tradit Complement Med       Date:  2021-11-23

6.  Medicinally Used Asarum Species: High-Resolution LC-MS Analysis of Aristolochic Acid Analogs and In vitro Toxicity Screening in HK-2 Cells.

Authors:  Johanna Michl; Olusheyi Bello; Geoffrey C Kite; Monique S J Simmonds; Michael Heinrich
Journal:  Front Pharmacol       Date:  2017-05-22       Impact factor: 5.810

7.  Revealing a Pre-neoplastic Renal Tubular Lesion by p-S6 Protein Immunohistochemistry after Rat Exposure to Aristolochic Acid.

Authors:  Alexandra Gruia; Patrycja Gazinska; Diana Herman; Valentin Ordodi; Calin Tatu; Peter Mantle
Journal:  J Kidney Cancer VHL       Date:  2015-09-08

8.  Rapid Identification and Simultaneous Quantification of Aristolochic Acids by HPLC-DAD and Confirmations by MS in Aristolochia chilensis Using a Limited Biomass.

Authors:  Michael Araya; Samantha García; Marcia González-Teuber
Journal:  J Anal Methods Chem       Date:  2018-06-06       Impact factor: 2.193

9.  Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo.

Authors:  Jingjing Wan; Ruixue Chen; Zhou Yang; Jing Xi; Yiyi Cao; Yu Chen; Xinyu Zhang; Yang Luan
Journal:  Arch Toxicol       Date:  2021-07-05       Impact factor: 5.153

10.  π-π-Induced aggregation and single-crystal fluorescence anisotropy of 5,6,10b-tri-aza-acephenanthrylene.

Authors:  Katarzyna Ostrowska; Davide Ceresoli; Katarzyna Stadnicka; Marlena Gryl; Marco Cazzaniga; Raffaella Soave; Bogdan Musielak; Łukasz J Witek; Piotr Goszczycki; Jarosław Grolik; Andrzej M Turek
Journal:  IUCrJ       Date:  2018-04-18       Impact factor: 4.769

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.